News Europe German Medical Cannabis Scripts Mainly For Pain

German Medical Cannabis Scripts Mainly For Pain

-

Advertising

PAIN is most common ailment for which patients are prescribed medical cannabis, say the German Government 

The introduction of its medical cannabis programme in 2017 saw physicians allowed to prescribe medicinal cannabis for over 60 illnesses.

Almost three quarters of all prescriptions from a Government sample of over 6,500 are for pain – at 71%

This was followed by spasticity – a muscle condition at 11% – and anorexia at 7%, with epilepsy,  migraines, ADHD and Tourettes Syndrome all featuring, too.

The data is based on an ongoing government survey involving 6,538 patients, as of September last year, reports the Marijuana Business Daily website.

This survey on the medical market will run until March 2022 and will then be used determine the future of medical cannabis insurance coverage.

Germany’s medical cannabis programme began in March 2017, and 

‘The Germany Cannabis Report’  by  Prohibition Partners  estimates 60,000 patients have been helped.

One of the most pressing issues in the German market is that it does not have the supply chain to satiate demand and has consequently granted supply licenses to three Canadian, and one domestic, producer while it  encourages the development of a homegrown industry.

This comes an estimated four million Germans use cannabis, with 17% of 18 to 25-year-olds saying they had used it in the past 12 months.

Despite being illegal, the state will not usually prosecute anyone found to have six grams of cannabis, or less – a limit agreed by state interior ministers, in 2018.

https://mjbizdaily.com/new-data-reveals-to

Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Europe’s Top Judges Praised For Their ‘Courage’ In Delivering Major Boost To CBD Industry

KANAVAPE lawyer Eveline Van Keymeulen has praised five of Europe’s most senior judges for their courage in rejecting the...

Markets: US Firm Swoops For UK Medical Cannabis Company, EMMAC, Alphagreen, Ananda et al…

AMERICAN firm Halo Labs has snapped up UK medicinal cannabis supplier Canmart in a share-based deal. Kent-based Canmart was one...

Walking In The Light With Carlos Santana And Prohibition Partners

MUSIC legend Carlos Santana rounded-off this year’s second Prohibition Partners Live discussing his new cannabis venture, his relationship with...

European Commission Under Increasing Pressure To Scrap Its Classification Of CBD As A Narcotic Drug Following Court Ruling

THE European Court of Justice has handed the continent’s hemp and CBD industry a major boost - now the...

Advertising

Huge Result For CBD Industry With Europe’s Top Court Saying It Is Not A Narcotic

THE KanaVape ruling is in and it's a massive win for the CBD industry with the ECJ saying that...

KanaVape’s Antonin Cohen Speaks To BusinessCann After Winning His Six-Year CBD Court Battle With Europe

A JOYFUL Antonin Cohen has spoken of his delight - and relief - after successfully winning a court battle...

Must read

Europe’s Top Judges Praised For Their ‘Courage’ In Delivering Major Boost To CBD Industry

KANAVAPE lawyer Eveline Van Keymeulen has praised five of...

Markets: US Firm Swoops For UK Medical Cannabis Company, EMMAC, Alphagreen, Ananda et al…

AMERICAN firm Halo Labs has snapped up UK medicinal...

Advertising

You might also likeRELATED
Recommended to you